Ticagrelor and Statins: Dangerous Liaisons?
Sign Up to like & getrecommendations! Published in 2024 at "Cardiovascular Drugs and Therapy"
DOI: 10.1007/s10557-024-07624-7
Abstract: Polypharmacy is often necessary in complex, chronic, comorbid and cardiovascular patients and is a known risk factor for potential drug-drug interaction (DDI) that can cause adverse reactions (toxicity or therapeutic failure). Anti-thrombotic drugs (largely low-dose… read more here.
Keywords: statins dangerous; ddi; dangerous liaisons; drug ... See more keywords